Siddik Sarkar

Employment

• Indian Institute of Chemical Biology Senior Scientist
  2023 - Present
• Academy of Scientific and Innovative Research
  2018 - Present
• Indian Institute of Chemical Biology CSIR Scientist
  2018 - Present
• Rutgers The State University of New Jersey Research Scientist/ Postdoctoral Associate
  2015 - 2017
• Virginia Commonwealth University Postdoctoral Researcher
  2010 - 2015

Education

• Rutgers The State University of New Jersey Postdoctoral Associate
  2015 - Present
• Virginia Commonwealth University Postdoctoral Research
  2010 - 2015
• Indian Institute of Technology Kharagpur PhD
  2006 - 2010
• Indian Institute of Technology Roorkee MS
  2002 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (46)

• A new coumarin-pyridyl based probe for Zn(II) and effective detection of nitro aromatics by Zn(II) complex in aqueous medium: Live cell imaging and practical applications
  Journal of Molecular Structure 2026 5 citations DOI: 10.1016/j.molstruc.2025.143864
  +Save
• The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer
  2023 0 citations DOI: 10.1101/2023.06.19.545525
  +Save
• Genome characterization, phylogenomic assessment and spatio-temporal dynamics study of highly mutated BA variants from India
  Indian Journal of Medical Microbiology 2023 1 citation DOI: 10.1016/j.ijmmb.2022.10.006
  +Save
• Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India
  2022 1 citation DOI: 10.1101/2022.01.28.22269987
  +Save
• Identification and Engineering of Aptamers for Theranostic Application in Human Health and Disorders
  2020 0 citations DOI: 10.22541/au.160823724.47148190/v1
  +Save
• Dysregulation of miRNA expression and their prognostic significance in paediatric cytogenetically normal acute myeloid leukaemia
  British Journal of Haematology 2020 4 citations DOI: 10.1111/bjh.16375
  +Save
• Bioengineered adipose-derived stem cells for targeted enzyme-prodrug therapy of ovarian cancer intraperitoneal metastasis.
  Journal of controlled release : official journal of the Controlled Release Society 2019 25 citations DOI: 10.1016/j.jconrel.2019.09.006
  +Save
• A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer
  Cancer Medicine 2018 11 citations DOI: 10.1002/cam4.1631
  +Save
• Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer
  Molecular Pharmaceutics 2018 33 citations DOI: 10.1021/acs.molpharmaceut.8b00218
  +Save
• Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment
  Langmuir 2017 43 citations DOI: 10.1021/acs.langmuir.7b01072
  +Save